Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 April 2025 | Story Onthatile Tikoe | Photo Supplied
Louzanne Coetzee
Louzanne Coetzee, a visually impaired Paralympic champion, has been elected to SASCOC’s Athletes Commission.

Louzanne Coetzee, a Paralympian and trailblazer in South African sport, has always embodied resilience, determination, and a passion for pushing boundaries. Recently, Coetzee achieved another milestone in her career – being selected to serve on the Athletes Commission of the South African Sports Confederation and Olympic Committee (SASCOC) for the next Olympic and Paralympic cycle. For Coetzee, this recognition is not just a personal achievement but an opportunity to drive meaningful change for athletes, particularly those with disabilities.

“Being selected as part of the SASCOC Athletes Commission is a great privilege,” she says. “It gives me the opportunity to represent athletes at the SASCOC level and take their issues forward. I was part of the previous commission, and I look forward to building on the work we have already started.”

As a visually impaired (classification T11) athlete with a distinguished career, Coetzee’s experiences inform her approach to this new role. Although she is not directly part of the SASCOC board, her seat on the Athletes Commission allows her to act as a crucial advocate for athletes, contributing to decisions that impact South African sport. “The commission will have its training soon, and we will learn more about our new responsibilities there,” she explains. “But my focus is clear: I want to improve classification opportunities for para-athletes and contribute towards enhancing high-performance athlete support in South Africa.”

Her vision extends beyond just the athletes she represents – she recognises the unique challenges that athletes with disabilities face. “The drive to succeed needs to come from within. You, as an athlete, are responsible for your performance, and that mindset is essential,” Coetzee says. She adds that the commission hosts athlete indabas, where athletes can voice their concerns and share the challenges they face. “We will continue to address these issues and work towards solutions that make a real difference.”

Coetzee has a clear message for young athletes with disabilities: “Your drive for success needs to be part of who you are. You alone control whether you succeed. And when challenges arise, don’t be afraid to voice them and seek assistance. Be creative in finding solutions to your unique challenges.”

Her advice extends beyond the competitive arena. After balancing a successful athletic and academic career with leadership aspirations, she emphasises the importance of time management for those seeking to excel both in sport and leadership. “It might be hard to do both, but it’s achievable if you plan properly,” she says, offering valuable guidance for aspiring athletes who wish to follow in her footsteps.

Her passion for improving inclusivity and accessibility in South African sport drives her to advocate for greater awareness of para-sports. “I want more people to know these athletes and support them on their journey,” she says. “There needs to be more awareness regarding para-sport, and as athletes we need to speak up. If we don’t, things won’t change for the betterment of us as athletes.”

Despite her incredible achievements, Coetzee remains motivated by a simple love for her sport. “I really enjoy what I do. It’s not just a job; it’s a passion,” she says. She also emphasises the importance of diverse representation on boards like SASCOC. “It’s vital that athletes have a say in the decision-making processes that impact their careers,” she says. “If we don’t speak up, things won’t change.”

Her success is also a testament to the support and opportunities she has received throughout her journey. “Everyone at the University of the Free State (UFS), especially KovsieSport and the Centre for Universal Access and Disability Support (CUADS), has played a major role in my success,” she says. “The support has helped me compete at the highest level while remaining academically strong. I am truly honoured to be backed by such a great institution.”

Finally, Coetzee calls on the public to help raise awareness and support for athletes with disabilities. “Show support for these athletes, be interested in the sports they play, and watch Paralympic sports when available. Be vocal about your support, as that can make a huge difference in recognition and opportunity,” she encourages.

As Louzanne Coetzee continues to break barriers and inspire others, her commitment to improving the lives of athletes, especially those with disabilities, remains unwavering. Through her leadership on the SASCOC Athletes Commission, she is not just advocating for athletes today but also paving the way for future generations to succeed in an inclusive and supportive sporting environment.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept